Drug General Information
Drug ID
D07RPV
Former ID
DNC008843
Drug Name
HALOPEMIDE
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529914]
Structure
Download
2D MOL

3D MOL

Formula
C21H22ClFN4O2
Canonical SMILES
C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCNC(=O)C4=CC=C(C=C4)<br />F
InChI
1S/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)
InChIKey
NBHPRWLFLUBAIE-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Phospholipase D1 Target Info Inhibitor [529914]
Phospholipase D Target Info Inhibitor [529914]
BioCyc Pathway Phospholipases
KEGG Pathway Glycerophospholipid metabolism
Ether lipid metabolism
Metabolic pathways
Ras signaling pathway
cAMP signaling pathway
Sphingolipid signaling pathway
Endocytosis
Fc gamma R-mediated phagocytosis
Glutamatergic synapse
GnRH signaling pathway
Pathways in cancer
Pancreatic cancer
Choline metabolism in cancer
PANTHER Pathway Angiogenesis
Ras Pathway
Pathway Interaction Database RhoA signaling pathway
Arf6 trafficking events
CDC42 signaling events
Arf6 downstream pathway
mTOR signaling pathway
ErbB1 downstream signaling
IL8- and CXCR1-mediated signaling events
Alpha-synuclein signaling
Reactome Role of phospholipids in phagocytosis
WikiPathways EGF/EGFR Signaling Pathway
TSH signaling pathway
References
Ref 529914Nat Chem Biol. 2009 Feb;5(2):108-17. Epub 2009 Jan 11.Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
Ref 529914Nat Chem Biol. 2009 Feb;5(2):108-17. Epub 2009 Jan 11.Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.